NCT01937702已完成1 期
A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- injection pain
研究概览
简要总结
A trial, investigating the influence of injection speed and volume on the perception of subcutaneous injection pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 74 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject has signed the informed consent form prior to screening
- •Age 18-74 years at screening (both included)
排除标准
- •Known or suspected hypersensitivity to needle, ink ball pen or other that are in contact with the injection area during the clinical visit
- •Previous participation in this trial. Participation is defined as having received at least one injection
研究组 & 干预措施
Anti-diabetes medication
Experimental
Insulin
干预措施: 0.9% NaCl (sodium chloride) (Other)
结局指标
主要结局
injection pain
时间窗: within 24 hours after injection
次要结局
- variability of injection pain(within the first 24 hours after injection)
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
2 期
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA PainOsteoarthritis, KneeNCT04809376Paradigm Biopharmaceuticals USA (INC)602
Unknown
2 期
Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 DiabetesType 1 DiabetesNCT01684956Massachusetts General Hospital20
已完成
不适用
Rapid Injection Technique Without AspirationPainNCT03723421Çankırı Karatekin University70
招募中
1 期
Investigating the effect of mesenchymal stem cell injection on reducing complications in patients with liver cirrhosisReducing complications of liver failure in patients with decompensated liver cirrhosis.Congenital cirrhosis (of liver)P78.81IRCT20140911019125N11Kerman University of Medical Sciences10
已完成
3 期
Subcutaneous Versus Intravenous Morphine When Switching From Oral to Parenteral Route in Palliative Cancer PatientsPain CancerNCT05236647University Hospital, Akershus60